Article Details
Retrieved on: 2022-03-09 04:41:40
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Physician-reported and patient audit data reveal increased real world use of SGLT2 inhibitors (AstraZeneca's Farxiga, Vifor/Janssen's Invokana, ...
Article found on: www.prnewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here